Anti-Mouse CD24 - Dylight® 550
| Code | Size | Price |
|---|
| LEI-C424-50ug | 50 ug | £162.00 |
Quantity:
| LEI-C424-250ug | 250 ug | £263.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rat
Antibody Isotype: IgG2b κ
Antibody Clonality: Monoclonal
Antibody Clone: M1/69
Regulatory Status: RUO
Target Species: Mouse
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Flow Cytometry
- Fluorescence-activated cell sorting (FACS)
- Immunofluorescence (IF)
- Immunohistochemistry (IHC)
- Inhibition Assay
- Western Blot (WB)
Storage:
This DyLight® 550 conjugate is stable when stored at 2-8°C. Do not freeze.
Further Information
Antigen Distribution:
CD24 is expressed on B cells, T cells, neutrophils, eosinophils, macrophages, neural cells, ganglion cells, keratinocytes, muscle cells, pancreas cells, lymphocytes, granulocytes, epithelial cells, thymocytes, monocytes, erythrocytes, dendritic cells and is overexpressed in many cancers. Expression varies during T and B cell differentiation. Peripheral T cells are mainly negative.
Concentration:
0.5 mg/ml
Conjugate/Tag/Label:
DyLight® 550
Format:
This DyLight® 550 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Formulation:
This DyLight® 550 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Long Description:
Mouse CD24 is a small 27 amino acid sialoglycoprotein that is anchored to plasma membranes via a glycosyl-phosphatidylinositol linker1. CD24 is widely distributed and plays a role in many diverse functions including adaptive immunity, inflammation, autoimmunity, and cancer1,2. CD24 modulates growth and differentiation signals to granulocytes and B cells, is required for homeostatic cell renewal, binds to P-selectin on activated endothelial cells, plays a role in cell adhesion3, lymphocyte proliferation for homeostatic purposes4, lymphocyte costimulation via CD28-independent pathways5 as well as a crucial role in cell selection and maturation during hematopoiesis.
CD24 tends to be expressed more abundantly in progenitor cells and metabolically active cells relative to terminally differentiated cells2. For example, CD24 is expressed on B-cell progenitors and mature resting B cells, but not terminally differentiated plasma cells. Similarly, CD24 is abundantly expressed on immature T cells and activated T cells but weakly expressed on peripheral T cells. As such, CD24 is used as a marker for the differentiation of hematopoietic and neuronal cells as well as tumor stem cells.
In humans, CD24 is overexpressed in various malignancies and its downregulation reduces cell tumorgenicity6. When CD24 is expressed early during carcinogenesis and blocked with monoclonal antibodies or small interfering RNA, tumor growth in xenograft mouse models is reduced.
M1/69 was generated by fusing the spleen cells of a DA rat immunized with B10 mouse spleen cells enriched for T cells with cells from a nonsecreting mouse myeloma line (NSI)7.
NCBI Gene:
12484
Target:
CD24
References
1. Kay R, Takei F, Humphries RK. J Immunol. 145:1952?1959. 1990.
2. Fang X, Zheng P, Tang J, et al. Cell Mol Immunol. 7(2):100-103. 2010.
3. Aigner S, Ruppert M, Hubbe M, et al. Int Immunol. 7:1557?1565. 1995.
4. Li O, Zheng P, Liu Y. J Exp Med. 200:1083?1089. 2004.
5. Hubbe M, Altevogt P. Eur J Immunol 24:731?737. 1994.
6. Sagiv E, Starr A, Rozovski U, et al. Cancer Res. 68(8):2803-2812. 2008.
7. Springer T, Galfr? G, Secher DS, et al. Eur J Immunol. 8(8):539-551. 1978.
8. Takei F, Secher DS, Milstein C, et al. Immunology. 42(3):371-378. 1981.
9. Gracz AD, Ramalingam S, Magness ST. Am J Physiol Gastrointest Liver Physiol. 298(5):G590-G600. 2010.
10. Shafer MER, Nguyen AHT, Tremblay M, et al. Stem Cell Reports. 8(4):1018-1031. 2017.
11. Shortman K, Wilson A, Egerton M, et al. Cell Immunol. 113(2):462-479. 1988.
12. Veillette A, Z??iga-Pfl?cker JC, Bolen JB, et al. J Exp Med. 170(5):1671-1680. 1989.
13. Koni PA, Flavell RA. J Exp Med. 189(5):855-864. 1999.
14. Chappaz S, Flueck L, Farr AG, et al. Blood. 110(12):3862-3870. 2007.
15. Rucci F, Notarangelo LD, Fazeli A, et al. Proc Natl Acad Sci U S A. 107(7):3024-3029. 2010.
16. Teague TK, Tan C, Marino JH, et al. Int Immunol. 22(5):387-397. 2010.
17. Qiu Q, Ravens I, Seth S, et al. J Immunol. 184(4):1681-1689. 2010.
18. Young GR, Terry SN, Manganaro L, et al. J Virol. 92(1):e01507-17. 2017.
19. Gubin MM, Esaulova E, Ward JP, et al. Cell. 175(4):1014-1030.e19. 2018.
20. Evrard M, Kwok IWH, Chong SZ, et al. Immunity. 48(2):364-379.e8. 2018.
21. Schneppenheim J, Loock AC, H?ttl S, et al. J Immunol. 199(1):172-185. 2017.
22. Hoves S, Ooi CH, Wolter C, et al. J Exp Med. 215(3):859-876. 2018.
23. Lee JY, Kim J, Yi J, et al. Front Immunol. 9:437. 2018.
24. Fiege JK, Stone IA, Dumm RE, et al. PLoS Pathog. 15(9):e1008077. 2019.
25. Krovi SH, Kappler JW, Marrack P, et al. Proc Natl Acad Sci U S A. 116(44):22252-22261. 2019.
26. Wu W, Shi Y, Xia H, et al. Sci Rep. 7:44481. 2017.
27. Arkatkar T, Jacobs HM, Du SW, et al. Kidney Int. 94(4):728-740. 2018.
28. Chappel MS, Hough MR, Mittel A, et al. J Exp Med. 184(5):1639-1649. 1996.
29. Liu JQ, Carl JW Jr, Joshi PS, et al. J Immunol. 178(10):6227-6235. 2007.
30. Wagner G, Lindroos-Christensen J, Einwallner E, et al. Sci Rep. 7:40881. 2017.
31. Chen CY, Kimura H, Landek-Salgado MA, et al. Endocrinology. 150(1):492-499. 2009.